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ABSTRACT
Background Although asthma has emerged as an 
important public health problem over recent decades in 
Latin America, there are limited published data on national 
hospital admission and mortality rates for asthma from 
countries in the region.
Objective To analyse trends in asthma hospitalisation and 
mortality rates in Ecuador over a 19- year period from 2000 
to 2018.
Methods Hospital discharge and death certificates listing 
asthma, as defined in the International Classification of 
Diseases 10th Revision codes (J45 and J46), were used 
to analyse time trends in rates of hospital admissions and 
mortality for asthma. The data were obtained from the 
Ecuadorian National Institute of Statistics and Census. 
Crude and age- standardised rates were estimated for the 
entire population. Additionally, specific rates by sex, age 
and region were estimated. We used joinpoint analysis to 
identify national trends.
Result During 2000–2018, a total of 58 250 
hospitalisations and 1328 deaths due to asthma were 
identified. The average annual rates for hospitalisation 
and mortality attributed to asthma were estimated to 
be 21 (95% CI 19.3 to 22.8) and 5.2 (95% CI 4.4 to 6.0) 
per 100 000 population, respectively, over this period. 
Asthma hospital admissions decreased from 28 to 13.7 
per 100 000 population between 2000 and 2018, and 
asthma mortality decreased from 0.8 to 0.3 per 100 000 
population over the same period. Based on jointpoint 
analysis, two temporal trends were identified for 
hospital admissions. Between 2000 and 2011, hospital 
admissions decreased 0.8% per year and between 
2011 and 2018 decreased 6.6% per year (p<0.05). On 
average, hospitalisation rates decreased 3.1% per year 
(p<0.05) over the entire study period. Mortality rate 
decreased 5.6% per year (p<0.05) over the 19- year 
period. Hospitalisation rates were higher among females, 
those aged 5 to 19 years and those living in the Coast 
region.
Conclusions Our analysis shows a temporal trend 
of reduction in rates of hospitalisations and deaths 
attributed to asthma between 2000 and 2018 in Ecuador, 
consistent with similar trends elsewhere in the Latin 
American region. Health registration systems in Latin 
America need to be improved to provide reliable data for 
future between and within country comparisons of trends 
in asthma hospitalisations and deaths.
INTRODUCTION
Over recent decades, asthma has emerged as 
a major challenge for health systems world-
wide affecting individuals of all ages.1 While 
the global prevalence of asthma is difficult 
to estimate with precision because of lack 
of up- to- date information and data gaps, 
the most recent global estimates suggest 
that 339 million people worldwide have 
asthma.2 Asthma causes significant morbidity 
and direct and indirect costs, especially in 
low- income and middle- income countries 
(LMICs).3 Poor control of asthma symptoms 
in LMICs because of inadequate access to 
health care and medications frequently leads 
to emergency room visits, hospitalisations and 
occasionally deaths.
Although hospitals admissions and 
mortality rates for asthma have decreased 
worldwide, especially in high- income coun-
tries (HICs), >80% of asthma deaths occur 
in LMICs.2 3 In developing regions as Latin 
America (LA), mortality rates are particularly 
high among poor marginalised urban popula-
tions where underdiagnosis, undertreatment 
and poor access to healthcare are important 
Key messages
 ► What are the trends in asthma hospital admissions 
and mortality rates from 2000 to 2018 in Ecuador by 
sex, age and region?
 ► Although a considerable body of literature docu-
menting asthma prevalence and determinants has 
emerged from Latin America over the past 20 years, 
there are still limited published data on asthma hos-
pitalisation and mortality rates from countries in the 
region.
 ► This study provided, at a national level, a compre-
hensive perspective on trends and disparities in 
hospitalisations and mortality related to asthma ex-
acerbations in Ecuador over a 19- year period.
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issues.4 However, although a considerable body of litera-
ture documenting asthma prevalence and determinants 
has emerged from LA over the past 30 or so years,4 5 there 
are still limited published data on asthma hospitalisation 
and mortality rates from the region. So far, only one study 
published in 1997 has evaluated asthma mortality rates 
between different LA countries.6 This study showed that, 
between 1980 and 1990, asthma mortality was high in 
most of the 11 countries studied.6 Recent studies have 
evaluated trends in asthma hospitalisations and asthma 
mortality by country: the few such studies from the region 
are from countries with relatively robust health registra-
tion systems such as Brazil, Mexico or Chile.7–9
In Ecuador, several studies have been conducted in 
the last two decades evaluating risk factors for asthma 
and other allergic diseases.10–14 However, little attention 
has been given to temporal trends on hospitalisations 
and deaths attributed to asthma. For such a middle- 
income country, it is important to estimate morbidity and 
mortality of asthma to provide key information on the 
health impact and prioritisation of the disease for public 
health authorities. The present study analysed trends in 
asthma hospitalisations and asthma mortality rates in 
Ecuador over a 19- year period between 2000 and 2018.
METHODS
Study setting
Ecuador is an upper- middle- income- country (figure 1) 
with a per capita income of US$6 080 in 2019.15 The 
country covers a total of 283 560 km2 and has four distinct 
geoclimatic regions: the Andean region that bisects the 
country North- South consisting of high mountainous 
terrain reaching an altitude of over 6000 m, interspersed 
by temperate and subtropical valleys; the Amazon region 
to the East of the Andes, an area primarily of lowland 
tropical forest; the Coast region to the west of the Andes, 
which includes both higher subtropical and lowland 
tropical areas and the Galapagos Islands approximately 
1,000 km to the West of the continent in the Pacific. The 
population of 17 511, 000 is ethnically diverse: 72% self- 
identify as Mestizo (mixture of Spanish and indigenous), 
7% Indigenous, 6% white, 7% Afro- Ecuadorian and 8% 
others. Quito and Guayaquil are the largest cities, each 
with approximately 3 million inhabitants.16 Petroleum 
and agriculture are the principal sources of income with 
oil accounting for 40% of the country’s exports.17 The 
poverty rate in Ecuador in 2019 was 25%.15
Ecuador has a fragmented health system including 
provision by institutions funded by the government, 
social security and private sectors.18 Public institutions 
offer healthcare services to the entire population and are 
divided into four levels of care.19 Social security institu-
tions offer health services only to those and their fami-
lies affiliated through employment. The private sector 
consists of for- profit entities (hospitals, clinics, dispen-
saries, doctor’s offices, pharmacies and prepaid medi-
cine companies) and are generally located in the larger 
cities.18 According to the National Institute of Statistics 
and Censuses (INEC), there were a total of 4168 health 
institutions in the country in 2017, staffed by 37 293 
doctors mostly in the public sector.20 Public and private 
hospitals are required to report health and vital statistics 
data to the Ministry of Public Health and INEC.
Study design
We conducted an ecological times- series study to eval-
uate trends in hospital admissions and mortality rates 
for asthma in Ecuador. We analysed national databases 
based on hospitalisation records and death certificates 
for asthma over the 19- year period from 1 January 2000 
to 31 December 2018.
Data collection
Data were obtained from INEC, the government statis-
tical agency in Ecuador.16 INEC compiles data on educa-
tion, demography, employment, health, households, 
migration and other population characteristics. Data 
on hospital admissions and deaths certifications were 
taken from the Health Statistics section (https://www. 
ecuadorencifras. gob. ec/ documentos/web-inec/Sitios/
inec_salud/ index. html). We used the International Clas-
sification of Diseases 10th Revision codes J45 (asthma, 
including predominantly allergic asthma, non- allergic 
asthma, mixed asthma, asthma unspecified) and J46 
(status asthmaticus) to identify hospital discharge records 
and death certificates listing asthma as the primary reason 
for hospital admission or death. Annual midyear popula-
tion estimates, total and stratified according to sex, age 
and region, were obtained from INEC.
Statistical analysis
Annual crude and age- standardised rates (ASRs) per 
million population were estimated for the 19- year analysis 
Figure 1 Study area: political map of Ecuador.
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period. ASRs were calculated using the direct method 
of standardisation with weights derived from WHO.21 
Additionally, crude rates by age group (≤5; 5–19; 20–44; 
45–64; >64 years), sex and region (Coast, Andean and 
rest of the country) were estimated for hospitalisation 
and mortality data.
Joinpoint regression models were used to evaluate 
trends in asthma hospital admissions and mortality rates 
over the study period.22 This method identifies the year(s) 
when a trend change is produced by connecting several 
different line segments on a log scale at ‘joinpoints’. The 
analysis starts with zero joinpoints (ie, a straight line) 
and then identifies points where a statistically signifi-
cant change over time in the linear slope of the trend 
occurred, adding these points to the model. Joinpoint 
method provides the Annual Percentage Change (APC) 
in rates between trend- change points, and estimates also 
the Average Annual Percentage Change (AAPC) over the 
whole study period. The APC is tested to determine if 
it differs from that expected under the null hypothesis 
(ie, APC is 0%). In the final model, each joinpoint indi-
cates a statistically significant change in trends (increase 
or decrease) and each of those trends is described by an 
APC. When there are no joinpoints (ie, no changes in 
trend), APC is constant and equals AAPC.
We conducted joinpoint analysis for the total popula-
tion and stratified by age group, sex and region using 
crude hospitalisation and mortality rates. APC and AAPC 
were calculated with 95% CI. P value <0.05 was consid-
ered statistically significant. Asthma hospital admissions 
and mortality rates were estimated using Epidat (V.4.2) 
and joinpoint analyses using the Joinpoint software 
(V.4.8.0.1) of the Surveillance Research Programme of 
the US National Cancer Institute.23
Patient and public involvement
This analysis was based on anonymised secondary data 
from hospital discharge records and death certificates.
RESULTS
General characteristics of asthma hospital admissions and 
asthma mortality rates
Table 1 shows numbers and crude average annual rates 
for hospitalisations and deaths attributed to asthma for 
the total population and by variables of interest. In the 
case of hospital admissions, from 2000 to 2018, a total 
of 58 250 asthma hospital discharge records were iden-
tified in INEC databases. Of these, 31 227 (53.4%) were 
for females, 20 605 (35.4%) were for 5–19 years and 
31 597 (54.2%) were from the Coast region. The average 
annual rate of asthma hospitalisations over the 19- year 
study period was 21 (95% CI 19.3 to 22.8) admissions per 
100 000 population. Average annual hospitalisation rates 
were highest among children below 5 years and in the 
Amazon region and Galapagos Islands.
A total of 1328 deaths were identified over the 19- year 
study period in Ecuador, of which 665 (50.1%) were 
females, 843 (59.3%) were aged >64 years and 782 
(58.9%) were living in the Coast region. The average 
annual asthma mortality rate was 0.5 (95% CI 0.44 to 
0.6) deaths per 100 000 population. Significantly higher 
mortality rates were observed among the population 
aged >64 years.
Trend analysis
Table 2 shows numbers and rates by year for asthma 
hospitalisations for the whole population and by age, 
Table 1 Number and average annual rates for asthma hospital admissions and mortality in Ecuador, 2000–2018
Characteristics
Hospital admissions 
for asthma n (%)
Average annual rate of 






mortality rate per 100 
000 population (95% CI)
Overall 58 250 (100) 21 (19.3 to 22.8) 1328 (100) 0.5 (0.44 to 0.6)
Sex
  Male 27 123 (46.6) 19.6 (18 to 21.2) 663 (49.9) 0.52 (0.43 to 0.59)
  Female 31 227 (53.4) 22.6 (20.5 to 24.7) 665 (50.1) 0.52 (0.42 to 0.61)
Age group (years)
  <5 16 087 (27.6) 51.9 (47.5 to 56.3) 128 (9) 0.44 (0.27 to 0.57)
  5–19 20 605 (35.4) 23.8 (22.4 to 25.1) 122 (8.6) 0.13 (0.09 to 0.18)
  20–44 8582 (14.7) 8.5 (7.4 to 9.5) 151 (10.6) 0.14 (0.11 to 0.17)
  45–64 6852 (11.8) 16.9 (14 to 19.7) 178 (12.5) 0.42 (0.33 to 0.51)
  >64 6119 (10.5) 37.6 (29.9 to 45.3) 843 (59.3) 4.9 (4.13 to 5.80)
Region
  Coast 31 597 (54.2) 22.8 (20.6 to 25.1) 782 (58.9) 0.59 (0.53 to 0.67)
  Andean 21 967 (37.8) 17.7 (16.5 to 19) 512 (38.5) 0.46 (0.32 to 0.59)
  Amazon and Galapagos 4500 (8) 32.4 (28 to 36.9) 34 (2.60) 0.27 (0.12 to 0.43)
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sex and region. Trend analysis in the whole population 
showed that crude and adjusted asthma hospitalisation 
rates decreased. ASRs decreased from 27.8 to 12.9 admis-
sions per 100 000 population between 2000 and 2018. 
Similarly, significantly decreasing trends were observed 
for hospital admission rates by sex, age and region over 
the study period (see table 2). Table 3 shows numbers and 
asthma mortality rates by year for the total population 
and by age, sex and region. Crude and adjusted mortality 
rates decreased in the study period. ASRs decreased from 
1.1 to 0.4 per 100 000 population between 2000 and 
2018. Significantly decreasing trends were also observed 
for asthma mortality rates by sex, age and region (see 
table 3).
Joinpoint analysis
Figure 2 and table 4 show joinpoint analysis for crude 
asthma hospitalisation and mortality rates. For the whole 
population, hospital admissions decreased 0.8% per year 
from 2000 to 2011 and 6.6% per year from 2011 to 2018 
(p<0.05) (figure 2). On average (AAPC), hospitalisa-
tion rates decreased 3.1% per year over the study period 
(table 4). Similarly, joinpoint analysis identified several 
trends in hospital admissions for crude rates by sex, age 
and region (see figure 3). For age groups of 0–4, 5–19, 
20–44, 45–64 and >64 years, the AAPC decreased 2.7%, 
1.4%, 4.3%, 6.2% and 7.88% per year, respectively, over 
the study period (figure 3A–E). For the male and female 
populations, the AAPC decreased 2.7% and 3.6% per 
year, respectively, over the study period (figure 3F,G). 
By region, the AAPC decreased 3.4% per year in the 
Coast region, 2.3% in the Andean region and 4.9% in 
the Amazon and Galapagos region, over the study period 
(figure 3H–J).
Figure 2 and table 4 show joinpoint analysis for crude 
asthma mortality rates. For the overall population, deaths 
decreased 5.6% per year (p<0.05) over the 19- year period 
(figure 2). Similarly, joinpoint analysis identified several 
trends in asthma mortality for crude rates by sex, age 
and region (see figure 4). For age groups of 0–4, 20–44, 
45–64 and >64 years, the AAPC decreased 11.1%, 5.6%, 
6% and 5.8% per year, respectively, over the study period 
(figure 4A–D). For the male and female populations, the 
AAPC decreased 5.6% and 5.7% per year, respectively, 
over the study period (figure 4E,F). By region, the AAPC 
decreased 3.8% per year in the Coast region and 9.7% 
per year in the Andean region (figure 4G,H). Joint-
point analysis technique is unable to work with zeros, 
so models for the population aged 5–19 years and for 
the population residing in the Amazon region and Gala-
pagos Islands were not calculated due to these groups 
presenting zero deaths in some years of the study period 
(see table 3).
Table 2 Crude rates, ASRs and group annual rates for asthma hospital admissions per 100 000 population, Ecuador 2000–
2018
Year
Hospital admissions Age groups (years) Sex Region
N Crude ASRs <5 5–19 20–44 45–64 >64 Male Female Coast Andean AG
2000 3513 28 27.8 62.8 28.2 11.9 28.7 60.9 25.3 30.8 29.6 24.1 49.1
2001 2812 21.9 22.2 45.6 21.3 10.1 21.9 57.4 18.8 25.1 22.8 18.9 40
2002 2919 22.3 22.0 50.1 21.4 10.7 21.1 50.1 19.7 26.6 23.3 18.5 44
2003 2933 22.0 21.6 55.3 20.1 9.2 21.7 49.2 19.4 24.8 22.4 19.5 40.2
2004 3208 23.7 23.3 61.6 19.2 10.4 24.6 55.3 21.3 26.1 25.0 19.9 43.6
2005 3409 24.8 24.0 61.7 23.6 11.1 19.4 59.0 23.2 26.5 26.2 21.0 43.7
2006 3057 21.9 21.4 49.6 20.6 10.5 20.9 47.6 19.9 23.9 22.9 19.3 33.6
2007 3381 23.8 22.4 62.1 24.9 9.1 18.5 46.7 22.5 25.0 27.7 18.5 31.5
2008 3574 24.7 23.2 62.5 25.9 10.2 20.4 43.9 24.1 25.3 28.4 19.6 33.3
2009 3277 22.2 21.0 53.7 23.8 9.2 18.9 40.3 20.6 23.9 25.4 17.1 36.7
2010 3344 22.3 20.6 53.2 27.0 9.1 15.7 35.0 21.2 23.3 25.7 17.7 28.7
2011 3320 21.7 19.9 58.2 26.7 7.3 15.5 30.9 20.7 22.8 26.5 15.5 29.0
2012 3207 20.7 18.9 54.4 26.4 8.2 13.4 24.2 20.0 21.3 23.5 16.3 31.8
2013 3103 19.6 18 48.7 26.5 8.0 11.9 24.0 18.3 21.0 22.9 15.7 23.5
2014 3092 19.3 17.6 53.9 27.0 6.1 11.5 21.2 18.9 19.7 21.4 16.4 24.0
2015 2657 16.3 15 44.0 23.3 5.4 9.8 18.3 16.0 16.6 16.8 14.8 24.6
2016 2676 16.2 14.9 43.7 23.9 4.9 9.6 18.5 15.4 16.9 15.8 16.0 21.3
2017 2435 14.5 13.6 32.4 22.2 5.6 8.7 17.5 13.7 15.4 14.1 14.3 20.4
2018 2333 13.7 12.9 33.7 20.6 5.1 8.7 14.6 13.0 14.4 13.6 13.5 17.1
AG, Amazon and Galapagos regions; ASR, age- standardised rate.
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DISCUSSION
To our knowledge, this is the first study from Ecuador 
to evaluate changes over time of hospital admissions and 
mortality from asthma. We did a time trend analysis to 
describe changes over a 19- year period (between 2000 
and 2018) in asthma hospitalisation and mortality rates 
using data from national hospital discharge records and 
death certificates. Our results showed significant reduc-
tions in asthma hospital admission and mortality rates in 
Ecuador over this period. Decreasing rates were observed 
for both sexes, and across all age groups and geo- climatic 
regions of the country, although the magnitude of these 
declines varied greatly by the factor studied with greatest 
reductions seen among the younger and older age 
groups (ie, <5 and >64 years), in the Coast region and 
among men.
Prior to 1980, asthma morbidity and mortality rates 
were seen to increase in HICs, leading to the suggestion 
of an asthma epidemic, although such trends appeared 
to stabilise or even decline after the 1980s.24 25 More 
limited data, however, have been available on asthma 
morbidity and mortality from LMICs. In the case of 
asthma mortality, several studies have been done in LA 
prior to 2000 showing high mortality rates for asthma 
during the 1980s and a trend of decreasing mortality up 
to 2000.6 26–29 A study evaluating data for 11 countries in 
the region between 1980 and 1992 showed that Uruguay 
and Mexico had the highest mortality rates (both with 
Table 3 Asthma mortality rates by age groups, sex and regions per 100 000 population
Year
Asthma mortality Age groups (years) Sex Region
N Crude ASRs 0–4 5–19 20–44 45–64 >64 Male Female Coast Andean AG
2000 106 0.8 1.1 1.1 0.24 0.32 0.73 8.3 0.72 0.98 0.89 0.85 0.35
2001 87 0.7 0.9 1.1 0.22 0.10 0.70 6.8 0.67 0.69 0.51 0.80 1.34
2002 85 0.6 0.8 0.8 0.29 0.23 0.39 5.9 0.70 0.60 0.53 0.82 0.33
2003 77 0.6 0.7 0.6 0.21 0.14 0.54 5.5 0.63 0.52 0.49 0.72 0.16
2004 86 0.6 0.7 0.8 0.23 0.22 0.52 5.6 0.66 0.60 0.56 0.73 0.61
2005 93 0.7 0.8 0.4 0.28 0.14 0.62 6.9 0.57 0.78 0.77 0.63 0.15
2006 83 0.6 0.7 0.2 0.14 0.23 0.35 6.5 0.69 0.50 0.66 0.59 0.00
2007 90 0.6 0.8 0.5 0.13 0.15 0.77 6.0 0.55 0.71 0.66 0.66 0.14
2008 88 0.6 0.7 0.5 0.16 0.17 0.28 6.3 0.68 0.54 0.79 0.45 0.27
2009 72 0.5 0.6 0.2 0.09 0.13 0.36 5.3 0.49 0.49 0.62 0.38 0.13
2010 78 0.5 0.6 0.5 0.07 0.17 0.60 4.4 0.54 0.50 0.72 0.30 0.51
2011 71 0.5 0.5 0.1 0.11 0.11 0.33 5.0 0.48 0.45 0.66 0.28 0.25
2012 54 0.3 0.4 0.2 0.08 0.11 0.24 3.3 0.35 0.34 0.58 0.12 0.12
2013 58 0.4 0.4 0.2 0.00 0.09 0.43 3.7 0.32 0.41 0.55 0.18 0.24
2014 67 0.4 0.5 0.4 0.17 0.09 0.31 3.7 0.40 0.43 0.60 0.24 0.23
2015 50 0.3 0.3 0.1 0.10 0.05 0.22 3.0 0.35 0.27 0.41 0.23 0.00
2016 46 0.3 0.3 0.1 0.04 0.10 0.25 2.5 0.26 0.30 0.45 0.11 0.11
2017 37 0.2 0.2 0.2 0.06 0.07 0.14 2.0 0.23 0.22 0.34 0.12 0.00
2018 54 0.3 0.4 0.1 0.00 0.14 0.24 3.0 0.30 0.34 0.51 0.25 0.11
AG, Amazon and Galapagos regions; ASR, age- standardised rate.
Figure 2 National trends in asthma hospital admissions 
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5.6 asthma deaths per million population) and Paraguay 
and Colombia had the lowest rates (0.8 and 1.35 per 
million, respectively).6 Recent studies using data for the 
last 20 years have shown that asthma mortality continues 
to decrease in the region among all age groups.8 30–33 For 
example, data from Costa Rica, Mexico, Brazil and Puerto 
Rico showed decreasing death rates of 80%, 26%, 10% 
and 42%, respectively.8 30 34 35 An study using data from 
WHO of 46 countries also showed trends of decreasing 
asthma mortality, as did studies conducted in Kuwait and 
the USA.25 36 37 Consistent with these findings, our data 
showed a reduction in crude asthma mortality rates of 
5.6% per year between 2000 and 2018. The tendency of 
decreasing mortality rates was most pronounced in young 
children (<5 years of age), among whom a decrease 
of 11.1% per year was observed over the study period. 
Similarly, national death rates in Brazil among children 
declined by 87% between 1980 and 2014.34
Analysis of time trends for asthma hospitalisations 
is more problematic, particularly for between- country 
comparisons, because of limitations in registration 
systems.2 Despite potential limitations, hospitalisation 
rates are frequently used as as an indicator for improve-
ments in asthma care and burden of morbidity, as well 
Figure 3 Trends in asthma hospital admissions per 100 000 population by age, sex and region, period 2000–2018. (A) 
Population aged 0-4 years; (B) population aged 5–19 years; (C) population aged 20–44 years; (D) population aged 45–64 
years; (E) population aged >64 years; (F) male population; (G) female population; (H) population residing in the Coast region; 
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as asthma severity and disease control.1 Of studies from 
HICs where registration data for asthma hospital admis-
sions are easily available, almost all have shown trends 
of reductions in hospitalisation rates over time over the 
last three decades, particularly in European countries.2 
Studies conducted in Kuwait (period 2000–2014) and 
Costa Rica (period 2000–2011) also showed a reduc-
tion in asthma hospital admissions rates of 16% and 
53%, respectively.35 36 A study from Brazil showed a 36% 
decrease in the absolute number of hospital admis-
sions between 2008 and 2013,34 while in Chile (period 
2000–2014) and Israel (period 1990–1999), the number 
of hospital admissions increased.38 39 Our data showed 
a decline of 6.6% per year in asthma hospitaliations 
between 2011 and 2018, which was even greater among 
those aged >64 years.
We found important differences in asthma hospital-
isation and mortality rates by age and between different 
regions of Ecuador. The average annual rate of hospi-
talisations in young children was 2–6 times greater 
compared to older age groups. This could be accounted 
for by asthma attacks caused by respiratory viral infec-
tions which affect younger children most.40 Populations 
living in Coast and Amazon regions accounted for 62% of 
hospital admissions over the 19- year observation period 
and showed higher hospitalisation rates compared with 
the Andean population. Such a difference could be 
accounted for by climatic factors (ie, predominantly trop-
ical vs temperate climates) that could alter patterns of 
risk factors for asthma attacks (eg, exposures to aeroal-
lergens). Interestingly, the phase I and III studies of the 
International Study of Asthma and Allergies in Child-
hood done in South American centres showed a pattern 
of higher asthma prevalence among children living in 
coastal cities with tropical climates.41 In this study, asthma 
mortality rates were similar among males and females, 
Figure 4 Trends in asthma mortality rate per 100 000 population by age, sex and region, period 2000–2018. (A) Population 
aged 0–4 years; (B) population aged 20–44 years; (C) population aged 45–64 years; (D) population aged >64 years; (E) male 
population; (F) female population; (G) population residing in the Coast region; (H) population residing in the Andean region. 
APC, Annual Percentage Change.
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an observation that runs contrary to other epidemio-
logical data: asthma prevalence, severity, exacerbation 
rates, hospitalisations and mortality are higher among 
women than men.42 A possible explanation could be a 
cultural factor: men are less likely to visit health services 
compared to women. This might explain a greater 
number ofasthma hospitalisations, but, because of the 
healthcare provided, a similar number of asthma- related 
deaths among women compared to men.
In the joinpoint analysis of asthma hospitalisation 
rates, we observed that rates decreased from 2011 for 
several of the categories for age, sex and region. This is 
unlikely to be explained by changes in registration meth-
odology (ie, not consistent across all categories), and 
might reflect trends of decreasing hospitalisation rates 
related to systematic changes in national management 
strategies and access to asthma medications. In Brazil, for 
example, a programme to manage and control asthma 
was implemented in the city of Salvador (ProAR), leading 
to a marked reduction in asthma hospitalisations.43 In 
Ecuador, a programme focused in reductions in the 
number of ambulatory hospitalisations for children <5 
years called Atencion Integrada a las enfermedades preva-
lentes de la Infancia could have contributed to decreased 
hospitalisations and deaths. Other factors that might 
have contributed to declines in asthma hospitalisation as 
well as death rates in Ecuador are the improvements in 
the national health system through policies of inclusion 
in social and public health programmes since 2005.44 45 
Additionally, although the country does not have national 
guidelines for asthma management, the widespread use 
of international guidelines such as those of the Global 
Initiative for Asthma could have contributed to improved 
asthma management and control nationally.
Our study has a number of important limitations. 
First, although the Ecuadorian registration system for 
deaths and hospital admissions has improved over the 
last decade, under- reporting (and under- recognition of 
asthma) remains an issue. However, this is unlikely to fully 
account for the observed long- term trends. Second, there 
are potential diagnostic limitations and imprecise data at 
the time death certificates are completed, especially in 
cases where ‘non- specific’ respiratory failure has been 
listed as the underlying cause of death. Third, diagnostic 
issues with respect to asthma are more common in chil-
dren <4 years of age due to similarities with other presen-
tations of respiratory disease. Diagnostic procedures such 
as spirometry are unsuitable in young children. Finally, 
we do not have data relating to hospitalisations such as 
disease severity, presence of comorbidities, adherence to 
maintenance treatment or therapy received .
CONCLUSIONS
Here, we have done a joinpoint analysis of national data 
from Ecuador for asthma hospitalisation and death rates 
over a 19- year period between 2000 and 2018. Our data 
show temporal trends of reductions in hospitalisation 
and death rates attributed to asthma and are gener-
ally consistent with data published elsewhere in the 
Latin American region. Trends of decreasing rates were 
observed for both sexes, all age groups and in all geo- 
climatic regions of the country. Future studies, evaluating 
potential links between asthma hospitalisations/deaths 
and health and social inclusion programmes as well as 
specific socioeconomic indicators, could provide insights 
into potential factors that underlie these national trends. 
Improvements are required to national health regis-
tries in the LA region to improve the quality and quan-
tity of information available on hospital admissions and 
mortality. We need to understand better how research 
using health registries can be used to improve health 
outcomes, especially in LMICs. Clinical data registries 
are extremely valuable when their use can be shown to 
improve quality of care and population health.
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